APA (7th ed.) Citation

C, X., F, X., R, W., Q, L., K, S., J, X., & L, L. (2021). Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review. Dove Medical Press.

Chicago Style (17th ed.) Citation

C, Xiao, Xu F, Wang R, Liang Q, Shen K, Xu J, and Liu L. Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review. Dove Medical Press, 2021.

MLA (8th ed.) Citation

C, Xiao, et al. Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review. Dove Medical Press, 2021.